Jason Wang

Changzhou Kanghui Medical Innovation Co., Ltd. is one of China's leading orthopedic companies, with products in the segments of Trauma, Spine, and Joint Implants & Instruments. With a history of high quality manufacturing and strong domestic sales and marketing capabilities, Kanghui has attracted strong institutional investor support from top tier venture capital companies, including IDG VC Partners, TDF, SIG, CDH and Vivo Ventures. KangHui is differentiated from its domestic competitors by its international orientation on product quality and innovation. They spend significantly on R & D to improve their products with a focus on maintaining market leadership in their product segments. Likewise, their quality control team (trained in manufacturing techniques and processes at Komatsu) has helped the company reach international standards in quality. Their collaborations with multi-national orthopedic companies, including Depuy (J&J), Smith & Nephew, Biomet, Stryker and Paragon, are a testament to the quality standards they set for the company.